Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
En el caso de los GLP-1 PATCHES (LUMESSA), no existe evidencia sobre su calidad, seguridad o eficacia, lo que puede poner en riesgo la salud de las personas
The results are consistent with the findings of a prior Phase IIb trial in that there was a very large placebo effect and no treatment effect, Transzyme said in a December 17, 2012, statement following the end of the latter trial, which assessed once-daily dosing
Each subsequent dose tends to produce milder side effects as the body adapts
The study also found no increased risk with other commonly used diabetes medications like metformin and insulin
The product generated $67.5 million in quarterly revenue, exceeding analyst expectations by 30%
